PMID: 28121423 | doi:10.1021/acs.biochem.6b01215 Akar S et al
This comprehensive analysis examines the clinical trial evidence for AOD-9604s safety profile, including participant numbers, study designs, reported adverse effects, metabolic safety markers, immunogenicity data, and how this peptides safety characteristics compare to related therapies
However, in a small number of cases, individuals using Neurobion may experience nausea, abdominal discomfort, diarrhea, or allergic reactions such as rashes, hives, itching, redness, blistering, and peeling skin
Similarly, with magnesium and other nutrients primarily stored in tissue, serum and plasma levels can remain "normal" even when tissue levels are low